[HTML][HTML] Epidemiology of coronary heart disease and acute coronary syndrome
F Sanchis-Gomar, C Perez-Quilis… - Annals of …, 2016 - ncbi.nlm.nih.gov
The aim of this review is to summarize the incidence, prevalence, trend in mortality, and
general prognosis of coronary heart disease (CHD) and a related condition, acute coronary …
general prognosis of coronary heart disease (CHD) and a related condition, acute coronary …
2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non–ST-elevation myocardial infarction: a report of the American College …
H Jneid, D Addison, DL Bhatt, GC Fonarow… - … Quality and Outcomes, 2017 - Am Heart Assoc
In the summer of 2015, the Task Force convened the writing committee to begin the process
of revising the existing set of performance measures for adult patients hospitalized with ST …
of revising the existing set of performance measures for adult patients hospitalized with ST …
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …
Authors/Task Force Members, CW Hamm… - European heart …, 2011 - academic.oup.com
ESC Guidelines 3002 recommendations. To implement the guidelines, condensed pocket
guidelines versions, summary slides, booklets with essential messages, and an electronic …
guidelines versions, summary slides, booklets with essential messages, and an electronic …
Contradicted and initially stronger effects in highly cited clinical research
JPA Ioannidis - Jama, 2005 - jamanetwork.com
ContextControversy and uncertainty ensue when the results of clinical research on the
effectiveness of interventions are subsequently contradicted. Controversies are most …
effectiveness of interventions are subsequently contradicted. Controversies are most …
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST …
JP Bassand, CW Hamm, D Ardissino… - European heart …, 2007 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …
for personal and educational use only. No commercial use is authorized. No part of the ESC …
Management of acute myocardial infarction in patients presenting with ST-segment elevation
F Van de Werf, D Ardissino, A Betriu… - European heart …, 2003 - academic.oup.com
The management of acute myocardial infarction continues to undergo major changes. Good
practice should be based on sound evidence derived from well-conducted clinical trials …
practice should be based on sound evidence derived from well-conducted clinical trials …
Renin–angiotensin–aldosterone system blockade for cardiovascular diseases: current status
TKW Ma, KKH Kam, BP Yan… - British journal of …, 2010 - Wiley Online Library
Activation of the renin–angiotensin–aldosterone system (RAAS) results in vasoconstriction,
muscular (vascular and cardiac) hypertrophy and fibrosis. Established arterial stiffness and …
muscular (vascular and cardiac) hypertrophy and fibrosis. Established arterial stiffness and …
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation
G Casaclang-Verzosa, BJ Gersh, TSM Tsang - Journal of the American …, 2008 - jacc.org
Left atrial (LA) structural and functional remodeling reflects a spectrum of pathophysiological
changes that have occurred in response to specific stressors. These changes include …
changes that have occurred in response to specific stressors. These changes include …
Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials
Background Angiotensin-converting-enzyme (ACE) inhibitors reduce cardiovascular
mortality and morbidity in patients with heart failure or left ventricular systolic dysfunction …
mortality and morbidity in patients with heart failure or left ventricular systolic dysfunction …
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study
P Jong, S Yusuf, MF Rousseau, SA Ahn, SI Bangdiwala - The Lancet, 2003 - thelancet.com
Background In the studies of left ventricular dysfunction (SOLVD), enalapril reduced
mortality in patients with symptomatic but not asymptomatic left ventricular systolic …
mortality in patients with symptomatic but not asymptomatic left ventricular systolic …